The current study will assess the real - life effectiveness of adalimumab in the management of Ankylosing Spondylitis (AS) with emphasis on the prevention and management of extra-articular manifestations.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01387802?cond=%22Arthritis%22&lup_s=07/28/2011&lup_d=30
